General Information of the Protein
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000073 , A-498
Biochemical Assays
Clinical Information about the Protein
Target 1 ( VEGFR1 messenger RNA (VEGFR1 mRNA) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 3 Target-related Diseases | 3 | |||
1 | Thrombocytopenia [ICD-11: 3B64] | ||||
2 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
3 | Alzheimer disease [ICD-11: 8A20] | ||||
Approved Drug(s) | 1 Approved Drug | 1 | |||
1 | Romiplostim | Approved | |||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | VATALANIB | Phase 2 | |||
2 | MK-2461 | Phase 1/2 |
Target 2 ( Vascular endothelial growth factor receptor 1 (FLT-1) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Renal cell carcinoma [ICD-11: 2C90] | ||||
2 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
Approved Drug(s) | 1 Approved Drug | 1 | |||
1 | Tivozanib | Approved | |||
Clinical Trial Drug(s) | 3 Clinical Trial Drugs | 3 | |||
1 | E-3810 | Phase 3 | |||
2 | Famitinib | Phase 2 | |||
3 | CEP-11981 | Phase 1 |
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID | Protein Name | Protein Organism | |
PT02141 | Vascular endothelial growth factor receptor 1 | Mus musculus, Mouse |
---|